This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Mi Ae Park: Innovator in Hemogenic Endothelial Cell Research
Introduction
Mi Ae Park is a prominent inventor based in Madison, WI (US). She has made significant contributions to the field of biomedical research, particularly in the area of hemogenic endothelial cells. Her innovative work focuses on enhancing T cell production through advanced methodologies.
Latest Patents
Mi Ae Park holds a patent titled "Induction of arterial-type of hemogenic endothelium (AHE) and enhancement of T cell production from PSCs through overexpression of ETS factors or modulating MAPK/ERK signalling pathways." This invention presents a method for creating a population of hemogenic endothelial cells with arterial specification and enhanced T cell potential. The method involves ETS transgene induction at the mesodermal stage of differentiation and activation of ERK and NOTCH signaling pathways.
Career Highlights
Mi Ae Park is associated with the Wisconsin Alumni Research Foundation, where she continues to advance her research. Her work has garnered attention for its potential applications in immunotherapy and regenerative medicine.
Collaborations
Some of her notable coworkers include Igor I Slukvin and Akhilesh Kumar, who contribute to her research endeavors.
Conclusion
Mi Ae Park is a trailblazer in the field of hemogenic endothelial cell research, with a focus on enhancing T cell production. Her innovative patent reflects her commitment to advancing biomedical science and improving therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile